Gene delivery by embryonic stem cells for malignant glioma therapy: Hype or hope?

Cancer Biology and Therapy

Volumn 7, Issue 9, 2008, Pages 1341-1347

  Germano, Isabelle M ^a   Uzzaman, Mahmud ^a   Keller, Gordon ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Gene therapy; Glioblastoma; Stem cells

Indexed keywords

ADENOVIRUS VECTOR; DOXYCYCLINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HERPESVIRUS VECTOR; PROTEIN S 100; RETROVIRUS VECTOR; TETRACYCLINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VESICULAR GLUTAMATE TRANSPORTER 1;

BLOOD BRAIN BARRIER; CELL CYCLE; CELL DIFFERENTIATION; CELL HOMING; CELL TRANSFER; CYTOTOXICITY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GLIA CELL; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; NEURAL STEM CELL; NICK END LABELING; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 52149111803     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.9.6711     Document Type: Review

References (52)

1. Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 1998; 40:151-60.
2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics 2003. CA Cancer J Clin 2003; 53:5-26.
3. Benveniste R, Germano IM. Evaluation of factors predicting accurate resection of high-grade gliomas using frameless image-guided stereotactic guidance. Neurosurgical Focus 2003; 14:1-4.
4. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al. ALA-Glioma Study Group. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008; 62:564-76.
5. CBTRUS, Central Brain Tumor Registry of the United States. Primary Brain Tumors in the United States: Statistical Report Tables 1998-2002. 2005; Available at http:// www. cbtrus.org/2005-2006/tables/2006.table18-19.pdf.
6. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996; 39:235-50.
7. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005; 2:3-14.
8. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol 2006; 176:1-40.
9. Lang AE, Lozano AM. Parkinson's disease: First of two parts. N Engl J Med 1998; 339:1044-53.
10. Spencer BJ, Verma IM. Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci USA 2007; 104:7594-9.
11. Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998; 42:1083-99.
12. Choi J, Wang S, Tung YS, Morrison B, Konofagou E. Trans-blood-brain barrier delivery of compounds at pharmacologically relevant molecular weights in the hippocampus of mice using Focused Ultrasound. J Acoust Soc Am 2008; 123:3217.
13. Zhang Y, Pardridge WM. Delivery of beta-galactosidase to mouse brain via the blood-brain barrier transferrin receptor. J Pharmacol Exp Ther 2005; 313:1075-81.
14. Chiocca EA. Gene therapy: A primer for neurosurgeons. Neurosurgery 2003; 53:364-73.
15. Rainov NG, Kramm CM. Recombinant retroviruses for treatment of malignant brain tumors. Int Rev Neurobiol 2003; 55:185-203.
16. Hampl JA, Camp SM, Mydlarz WK, Hampl M, Ichikawa T, Chiocca EA, et al. Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectors. Hum Gene Ther 2003; 14:611-26.
17. Germano IM, FableJ S, Gultekin H, Silvers A. Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas. J Neurooncol 2003; 65:279-89.
18. Chiocca EA. Oncolytic viruses. Nat Rev Cancer 2002; 2:938-50.
19. Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991; 252:854-6.
20. Fulci G, Dmitrieva N, Gianni D, Fontana EJ, Pan X, Lu Y, et al. Depletion of Peripheral Macrophages and Brain Microglia Increases Brain Tumor Titers of Oncolytic Viruses. Cancer Res 2007; 67:9398-406.
21. Lawler SE, Peruzzi PP, Chiocca EA. Genetic strategies for brain tumor therapy. Cancer Gene Ther 2006; 13:225-33.
22. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292:154-6.
23. Keller GM. Embryonic stem cell differentiation: emerge of a new era in biology and medicine. Gene & Development 2005; 19:1129-55.
24. French AJ, Adams CA, Anderson LS, Kitchen JR, Hughes MR, Wood SH. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells 2008; 26:485-93.
25. Hurlbut WB. Ethics and embryonic stem cell research: altered nuclear transfer as a way forward. BioDrugs 2007; 21:79-83.
26. Heese O, Disko A, Zirkel D, Westphal M, Lamszus K. Neural stem cell migration toward gliomas in vitro. Neuro Oncol 2005; 7:476-84.
27. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97:12846-51.
28. Arnhold S, Hilgers M, Lenartz D, Sekova I, Kochanek S, Voges J, et al. Neural precursor cells as carriers for a gene therapeutical approach in tumor therapy. Cell Transplant 2003; 12:827-37.
29. Ehtesham M, Samoto K, Kabos P, Acosta FL, Gutierrez MAR, Black KL, Yu JS. Treatment of intracranial glioma with in situ interferon gamma and tumor necrosis factor alpha gene transfer. Cancer Gene Ther 2002; 9:925-34.
30. Jandial R, Singec I, Ames CP, Snyder EY. Genetic modification of neural stem cells. Mol Ther 2008; 16:450-7.
31. Gerecht-Nir S, Itskovitz-Eldor J. Human embryonic stem cells: a potential source for cellular therapy. Am J Tranplant 2004; 4:51-7.
32. Brüstle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, et al. Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science 1999; 285:754-6.
33. Hu Z, Ulfendahl M, Olivius NP. Central migration of neuronal tissue and embryonic stem cells following transplantation along the adult auditory canal. Brain Research 2004; 1026:68-73.
34. Chiba S, Ikeda R, Kurokawa MS, Yoshikawa H, Takeno M, Nagafuchi H, et al. Anatomical and functional recovery by embryonic stem cell-derived neural tissue of a mouse model of brain damage. J Neurol Sci 2004; 219:107-17.
35. Park S, Kim EY, Ghil GS, Joo WS, Wang KC, Kim YS, et al. Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease. Neurosci Lett 2003; 353:91-4.
36. Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003; 23:137-49.
37. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, et al. Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002; 99:16267-72.
38. Benveniste RJ, Keller G, Germano I. Embryonic stem cell-derived astrocytes expressing drug-inducible transgenes: differentiation and transplantion into the mouse brain. J Neurosurg 2005; 103:115-23.
39. Gossen M, Bujard H. Tight control of gene-expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 96:8483-8.
40. Zhu Z, Zheng T, Lee CG, Homer RJ, Elias JA. Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Sem. Cell & Develop Bio 2002; 13:121-28.
41. Roth W, Isenmann S, Naumann U, Kugler S, Bahr M, Dichgans J, et al. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence neurotoxicity. Biochem Biophys Res Commun 1999; 265:479-83.
42. Saito R, Bringas JR, Panner A, Tamas M, Pieper RO, Berger MS, Bankiewicz KS. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer research 2004; 64:6858-62.
43. Germano IM, Uzzaman M, Benveniste RJ, Zaurova M, Keller G. Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand. J Neurosurg 2006; 105:88-95.
44. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004; 101:18117-22.
45. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007; 109:4055-63.
46. Schmidt NO, Przylecki W, Yang W, Ziu M, Teng Y, Kim SU, et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005; 7:623-9.
47. Ehtesham M, Yuan X, Kabos P, Chung NH, Liu G, Akasaki Y, et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004; 6:287-93.
48. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, et al. Safety and antitumor activity of recombinant soluable Apo2 ligand. J Clin Investig 1999; 104:155-62.
49. Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, Yong VW, et al. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res 2001; 61:1162-70.
50. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, Yu JS. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002; 62:7170-4.
51. Uzzaman M, Keller G, Germano IM. In vivo Gene Delivery by embryonic stem cell-derived astrocytes for malignant gliomas. Neuro-Oncology 2008; (in press).
52. Wilson PA, Hemmati-Brivanlou A. Induction of epidermis and inhibition of neural fate by Bmp-4. Nature 1995; 376:331-3.